[Federal Register Volume 78, Number 180 (Tuesday, September 17, 2013)]
[Notices]
[Pages 57166-57167]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-22502]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable materials, and personal information concerning

[[Page 57167]]

individuals associated with the grant applications, the disclosure of 
which would constitute a clearly unwarranted invasion of personal 
privacy.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; Ruth L. Kirschstein National Research Service Award 
(NRSA) Institutional Research Training Grants (T32).
    Date: October 16, 2013.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852.
    Contact Person: Eliane Lazar-Wesley, Ph.D., Scientific Review 
Officer, Office of Extramural Affairs, National Institute on Drug 
Abuse, NIH, DHHS, Room 4245, MSC 9550, 6001 Executive Blvd., 
Bethesda, MD 20892-9550, 301-451-4530, [email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; SEDAPA R25: PAR 13-084 R25 and PAR 10-227.
    Date: October 17, 2013.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852.
    Contact Person: Eliane Lazar-Wesley, Ph.D., Scientific Review 
Officer, Office of Extramural Affairs, National Institute on Drug 
Abuse, NIH, DHHS, Room 4245, MSC 9550, 6001 Executive Blvd., 
Bethesda, MD 20892-9550, 301-451-4530, [email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; HIV/AIDS and Substance Abuse.
    Date: October 17, 2013.
    Time: 1:15 p.m. to 3:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852, (Telephone Conference 
Call).
    Contact Person: Nadine Rogers, Ph.D., Scientific Review Officer, 
Office of Extramural Affairs, National Institute on Drug Abuse, NIH, 
DHHS, 6001 Executive Blvd., Room 4229, MSC 9550, Bethesda, MD 20892-
9550, 301-402-2105, [email protected].

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel; DIDARP: Diversity-promoting Institutions Drug Abuse 
Research Program (R24).
    Date: October 24, 2013.
    Time: 1:30 p.m. to 4:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852, (Telephone Conference 
Call).
    Contact Person: Nadine Rogers, Ph.D., Scientific Review Officer, 
Office of Extramural Affairs, National Institute on Drug Abuse, NIH, 
DHHS, 6001 Executive Blvd., Room 4229, MSC 9550, Bethesda, MD 20892-
9550, 301-402-2105, [email protected].

 (Catalogue of Federal Domestic Assistance Program Nos.: 93.279, 
Drug Abuse and Addiction Research Programs, National Institutes of 
Health, HHS)

    Dated: September 11, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2013-22502 Filed 9-16-13; 8:45 am]
BILLING CODE 4140-01-P